-
Mashup Score: 0Myriad Novel Devices Aim to Boost Decongestion in Acute HF - 1 year(s) ago
Researchers are mulling how best to study these devices targeting cardiorenal syndrome as adjuncts to diuretics.
Source: TCTMD.comCategories: Cardiology News and Journals, Latest HeadlinesTweet
-
Mashup Score: 0CVRx, Abbott share long-term heart failure data at THT 2023 - 1 year(s) ago
CVRx and Abbott used the second annual THT conference as an opportunity to present updated data on their signature heart failure solutions.
Source: Cardiovascular BusinessCategories: Cardiology News and Journals, Latest HeadlinesTweet-
ICYMI: CVRx, Abbott share long-term #heartfailure data at THT 2023 @AbbottCardio @cvrxceo @CVRx_Inc #THT2023 #cardiology #cardiotwitter https://t.co/qo597lhFcT
-
-
Mashup Score: 0
In a meta-analysis of three trials, remote hemodynamic monitoring was associated with reduced risk for death and HF hospitalization in patients with HF with reduced ejection fraction, researchers reported.During Technology and Heart Failure Therapeutics 2023, Cardiology Today Editorial Board Member JoAnn Lindenfeld, MD, FHFSA, professor of medicine at Vanderbilt University Medical Center,
Source: www.healio.comCategories: Cardiology News and Journals, Latest HeadlinesTweet-
ICYMI: "We believe these data will strengthen the overall analysis and this will spur greater use of hemodynamic monitoring in patients with HFpEF" @VUMChealth #cardiotwitter #THT2023 https://t.co/fF49XuEZhI
-
-
Mashup Score: 0
In a meta-analysis of three trials, remote hemodynamic monitoring was associated with reduced risk for death and HF hospitalization in patients with HF with reduced ejection fraction, researchers reported.During Technology and Heart Failure Therapeutics 2023, Cardiology Today Editorial Board Member JoAnn Lindenfeld, MD, FHFSA, professor of medicine at Vanderbilt University Medical Center,
Source: www.healio.comCategories: Cardiology News and Journals, Latest HeadlinesTweet-
ICYMI: "We believe these data will strengthen the overall analysis and this will spur greater use of hemodynamic monitoring in patients with HFpEF" @VUMChealth #cardiotwitter #THT2023 https://t.co/fF49XuEZhI
-
-
Mashup Score: 0
It’s clear the REVIVED-BCIS2 trial hasn’t put an end to PCI in this setting. But it should be used cautiously, Eric Velazquez says.
Source: TCTMD.comCategories: Cardiology News and Journals, Latest HeadlinesTweet-
For patients with HFrEF and CAD, what role does PCI play? Experts @dor_lotan, @ericvelazquezmd, and @JWMoses discuss the implications of REVIVED-BCIS2 and GDMT versus PCI. Don't miss our top story from #THT2023 from @ToddNeale: https://t.co/9Rnzv7bKs7 https://t.co/E9SczsGUdH
-
-
Mashup Score: 1
In a meta-analysis of three trials, remote hemodynamic monitoring was associated with reduced risk for death and HF hospitalization in patients with HF with reduced ejection fraction, researchers reported.During Technology and Heart Failure Therapeutics 2023, Cardiology Today Editorial Board Member JoAnn Lindenfeld, MD, FHFSA, professor of medicine at Vanderbilt University Medical Center,
Source: www.healio.comCategories: Cardiology News and Journals, Latest HeadlinesTweet-
In a meta-analysis of three trials, remote hemodynamic monitoring was associated with reduced risk for death and HF hospitalization in patients with HF with reduced ejection fraction @VUMChealth #cardiotwitter #THT2023 https://t.co/fF49XuErsa
-
-
Mashup Score: 0ALT FLOW: APTURE Transcatheter Shunt System Found Safe in Symptomatic HF Patients - American College of Cardiology - 1 year(s) ago
Left atrial to coronary sinus shunting using the APTURE transcatheter shunt system was found to be safe in patients with symptomatic heart failure (HF), resulting in reduction in pulmonary capillary wedge pressure (PCWP) as well as improvement in HF symptoms and quality of life, according to findings from the ALT FLOW Early Feasibility Study, a single-arm, late-breaking clinical trial…
Source: American College of CardiologyCategories: Cardiology News and Journals, Latest HeadlinesTweet-
Read more about the ALT FLOW Early Feasibility Study, a single-arm, late-breaking clinical trial presented at #THT2023 and simultaneously published in #JACCINT: https://t.co/YutzD6Ds8c #HeartFailure https://t.co/Z8Li6iTV77
-
-
Mashup Score: 0CVRx, Abbott share long-term heart failure data at THT 2023 - 1 year(s) ago
CVRx and Abbott used the second annual THT conference as an opportunity to present updated data on their signature heart failure solutions.
Source: Cardiovascular BusinessCategories: Cardiology News and Journals, Latest HeadlinesTweet-
CVRx, Abbott share long-term #heartfailure data at THT 2023 @AbbottCardio @cvrxceo @CVRx_Inc #THT2023 #cardiology #cardiotwitter https://t.co/z3rdZvSITD
-
-
Mashup Score: 0Program Guide | THT 2023 - 1 year(s) ago
Sign Up for Our NewsletterGet the latest news and information from CRF.By submitting your email address, you agree to CRF’s Privacy Policy & Terms and Conditions.1700 Broadway, 9th FloorNew York, NY 10019646.434.4500[email protected]© 2023, Cardiovascular Research Foundation. All rights reserved.Privacy PolicyTerms and Conditions of Use
Source: tht2023.crfconnect.comCategories: Cardiology News and Journals, Latest HeadlinesTweet-
Explore this deep dive into valvular disease in #heartfailure patients. Today at 8:00 AM. Only at #THT2023! https://t.co/gKVj9R0id4 @GAilawadiMD @SusheelKodaliMD @kp_rommel @hahn_rt @azeemlatib https://t.co/4bC0GWkHq1
-
-
Mashup Score: 1Program Guide | THT 2023 - 1 year(s) ago
Sign Up for Our NewsletterGet the latest news and information from CRF.By submitting your email address, you agree to CRF’s Privacy Policy & Terms and Conditions.1700 Broadway, 9th FloorNew York, NY 10019646.434.4500[email protected]© 2023, Cardiovascular Research Foundation. All rights reserved.Privacy PolicyTerms and Conditions of Use
Source: tht2023.crfconnect.comCategories: Cardiologists, Latest HeadlinesTweet-
RT @crfheart: Get the latest updates on amyloid heart disease! Today at 9:30 AM. Only at #THT2023! https://t.co/PJwpKJtnij @KMAlexanderMD…
-
For patients with acute heart failure, decongestion has long been an issue. At #THT2023, researchers presented novel technological approaches to decongestion, but how do these new devices work? Read the new feature from @ToddNeale: https://t.co/Aq5yBTjFMx https://t.co/OO8xDprGeZ